Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Continuous Dose Titration of Combination Therapy for Hypertension Using CURATE: AI Personalised Continuous Dose Titration Platform

NCT05376683 is registered in ClinicalTrials.gov with Alexandra Hospital as lead sponsor.

NCT NCT05376683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05376683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Continuous Dose Titration of Combination Therapy for Hypertension Using CURATE: AI Personalised Continuous Dose Titration Platform
Lead sponsor
Alexandra Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2023
Completion date
April 20, 2024
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hypertension